Oral administration of losartan influences aminopeptidase activity in the frontal cortex

European Neuropsychopharmacology

Volumn 10, Issue 4, 2000, Pages 279-282

  Prieto, Isabel ^a   Martínez, José M ^a   Hermoso, Francisco ^a   Ramírez, María J ^a   Vargas, Felix ^a   De Gasparo, Marc ^b   Alba, Francisco ^a   Ramírez, Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aminopeptidase activity; Frontal cortex; Losartan

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN 1 RECEPTOR; LOSARTAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034122138     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00083-3     Document Type: Article

References (11)

1. J.D. Bui B. Kimura M.I. Phillips Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood–brain barrier Eur. J. Pharmacol. 219 1992 147 151
2. P.M. Cummins B. O’Connor Bovine brain pyroglutamyl aminopeptidase (Type-I): Purification and characterisation of a neuropeptide-inactivating peptidase Int. J. Biochem. Cell Biol. 28 1996 883 893
3. M. De Gasparo S. Bottari N.R. Levens Characteristics of angiotensin II receptors and their role in cell and organ physiology J.H. Laragh B.M. Brenner Hypertension: Pathophysiology, Diagnosis, and Management 1995 Raven Press New York 1695 1720
4. L. Hein G.S. Barsh R.E. Pratt V.J. Dzau K. Kobilka Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice Nature 377 1995 744 747
5. J.K. McDonald J.A. Barret Mammalian Proteases Vol. 2 1986 Academic Press London 23 100
6. M. Migaud C. Durieux J. Viereck E. Soroca-Lucas M.C. Fournié-Zaluski B.P. Roques The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A Peptides 17 1996 601 607
7. C. Polidori R. Ciccocioppo P. Pompei R. Cirillo M. Massi Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood–brain barrier in rats Eur. J. Pharmacol. 307 1996 259 267
8. M. Ramı́rez I. Prieto J.M. Martı́nez F. Vargas F. Alba Renal aminopeptidase activities in animal models of hypertension Regul. Pept. 72 1997 155 159
9. M.K. Sim X.S. Qiu Formation of des-Asp-angiotensin I in the hypothalamic extract of normo and hypertensive rats Blood Press. 3 1994 260 264
10. S. Wilk E. Wilk R.P. Magnusson Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase J. Biol. Chem. 273 1998 15961 15970
11. J.W. Wright J.W. Harding Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions Regul. Pept. 59 1995 269 295